Dr. Elizabeth Nielson is a co-founder of Fluence and a psychologist with a focus on developing psychedelic medicines as empirically supported treatments for PTSD, substance use problems, and mood disorders. Dr. Nielson is a therapist on FDA approved clinical trials of psilocybin-assisted treatment of alcohol use disorder, MDMA-assisted treatment PTSD, and psilocybin-assisted treatment of treatment resistant depression. Through Fluence, she provides continuing education and training programs for therapists who wish to engage in integration of psychedelic experiences in clinical settings. Her program of research includes qualitative and mixed-methods projects designed to further understand the phenomenology and mechanisms of change in psychedelic-assisted therapy, including the experiences of trial participants and of the therapists themselves. Having completed an NIH postdoctoral fellowship at NYU, she has published and presented on topics of psychedelic therapist training, therapists’ personal experience with psychedelics, and including psychedelic integration in group and individual psychotherapy.
Dr. Ingmar Gorman is a co-founder of Fluence and a psychologist who specializes in assisting populations who have a relationship with psychedelics. He is the site co-principal investigator and therapist on a Phase 3 clinical trial studying MDMA-assisted psychotherapy for post-traumatic stress disorder. Dr. Gorman is a board member of Horizons Media, Inc., a not for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics. After completing his NIH postdoctoral fellowship at New York University, Dr. Gorman stepped down as director of the Psychedelic Education and Continuing Care Program to focus his efforts on Fluence and the training of future therapists.
Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy, addictions and psychedelic therapy. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psilocybin-assisted psychotherapy in the treatment of cancer related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psilocybin-Assisted treatment of Major Depressive Disorder, a collaborator with Yale University’s study on psilocybin-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS study on treatment of Post Traumatic Stress Disorder with MDMA-Assisted Psychotherapy. Jeff is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He co-authored a paper on the influence of therapists’ first hand experience with psychedelics on psychedelic-assisted psychotherapy research in The Journal of Psychedelic Studies. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies. He maintains a private practice in New York City.
Assistant Trainers are community role models in their practice of psychedelic harm reduction and integration. Having attended Psychedelics 101 & 102 and incorporated the material of into their professional lives they are present on a regular basis at our workshops to provide assistance with breakout groups, give feedback on role plays, lead contemplative practices or small bits of programming, participate in demonstrations, contribute ideas and experiences, and provide an example of how this workshop might facilitate the development of a new part of someone's career.
Johan Eriksson is a psychologist in private practice in Stockholm, Sweden. He has a background in cognitive behavioral therapy, Acceptance and Commitment Therapy (ACT), and intensive short-term dynamic psychotherapy (ISTDP). He works with clients for psychedelic preparation and integration, as well as general psychotherapy. In 2016 Johan co-founded the Swedish Network for Psychedelic Science (NPV), and in 2019 he arranged and participated in the first Psychedelics 101 and 102 in Sweden. He regularly attends psychedelic science conferences and recently co-author a peer-reviewed paper on ACT and psychedelic-assisted psychotherapy. His web page is www.psykologiskintegration.se.
Dr. Joe Flanders is a Psychologist and the founder and managing partner of Mindspace Wellbeing in Montreal, where he works as a therapist, certified mindfulness teacher and trainer, and consultant to organizations. He is also an Assistant Professor (Professional) in the Psychology Department at McGill University. Joe is the co-director of the Psychedelic Harm Reduction and Integration (PHRI) Program at Mindspace.
Leah Gooch teaches yoga, meditation, writing, and art in order to help individuals approach a deeper awareness of their existence. After teaching art in New York City for eight years she facilitated the creation of a mural inside of Crossroads Detention Center in Brooklyn, completed by fifteen justice-involved youth. Leah is currently a teacher and Recreation Program Leader at a correctional facility. She facilitates public and private workshops and yoga lessons and is a reiki master practitioner. Her website is fourminutesaday.org - a reference to her initial commitment to meditate for (at least!) four minutes a day.
David Gumpel is an Integral Master Coach and a qualified teacher of Mindfulness-Based Stress Reduction (MBSR) through UMASS medical school. David is the co-founder of Access Mindfulness and a research assistant for the MAPS sponsored MDMA-Assisted Psychotherapy for the treatment of post-traumatic stress study in NYC. He also is a site coordinator for the New York Psychiatric Institute’s Cognitive Behavioral Therapy Lab at Columbia University. As a coach, David teaches mindfulness to clients in private practice and to groups in corporate settings. Find him online at ebcpathways.com.
Jayne is a licensed Clinical Social Worker with 30 years of clinical experience and training. Non ordinary states of consciousness often offer clients extraordinary learning opportunities for deep and sustainable change, and Jayne offers support and integration guidance for those who are attracted to healing modalities such as plant medicine, ketamine, body centered therapies and breathwork. She is a MBSR teacher, experienced meditator, and co-founder of Access Mindfulness, a non-profit dedicated to bringing mindfulness to schools. She offers clinical services remotely and in person Midtown East, NYC and Woodstock, New York.
Rebecca is a licensed Clinical Social Worker and founder of Plant Parenthood, a digital and in-person community of parents who use psychedelics. At her private practice in Brooklyn, NY she works with creative professionals using mindfulness and experiential techniques to address depression, anxiety and life transitions. In addition, she works in the re-emerging clinical space of psychedelic harm reduction and integration, helping clients prepare for psychedelic experiences, incorporate insights or cope with challenges post-experience. Her experience includes Mindfulness-Based Stress Reduction, Mindfulness for Clinicians, Psychedelics 101 & 102, and Beyond Experience Psychedelic Integration Workshop.
Andrew is the Director of Programming and a mindfulness teacher at Mindspace Wellbeing in Montreal, where he oversees all group programming and teaches Mindfulness Based Stress Reduction. He is also the Co-Director of Mindspace’s Psychedelic Harm Reduction and Integration (PHRI) program where he provides harm reduction and integration services for clients and supports Mindspace’s growing team of therapists building their own competencies in psychedelic integration work. Prior to joining Mindspace he established a weekly integration group focused on exploring the relationship between psychedelics and meditation and mindfulness practices, and has also facilitated integration circles for the Montreal Psychedelic Society.
Michael is a psychologist based in Stockholm, Sweden. He is trained in the psychodynamic tradition, Acceptance and Commitment Therapy, and mindfulness-based interventions. He is a Mindfulness-Based Cognitive Therapy instructor, has worked with mediyoga, and teaches mindfulness meditation in his spare time. In 2016, he co-founded the Swedish Network for Psychedelic Science (NPV) and in 2019 he arranged and participated in the first Psychedelics 101 and 102, facilitated by Elizabeth Nielson and Ingmar Gorman, in Sweden. Michael was also co-investigator in a research study that examined the effects of oxytocin on non-ordinary states of consciousness.
No. Our trainings do not include any administration of any psychedelic compounds. While we recognize that such experiences can be a valuable part of training for some professionals in certain situations, we believe they are neither necessary nor sufficient, and value a more general familiarity with alternative states of consciousness.
Depending on the compound there may be a legal avenue to do so either by participating in a research trial, receiving treatment (as a patient) with a currently available psychedelic (e.g. ketamine), or traveling abroad.
Some of our programs offer the option to purchase APA CE and/or CME certificate. You will need to check with your licensing board in your state to see if those credits are acceptable for your purposes.
Our intention is to keep our fees affordable for working mental health professionals. At most of our programs we reserve select number of spaces for a discounted rate for applicants whose presence would benefit the community for whom our fee would be a hardship. We prioritize providing scholarships to participants whose participation will enhance diversity among clinicians educated in this modality and/or the populations to which it is available. Applications will be accepted and scholarships awarded on a rolling basis, so please apply early. Where available, you will find a link to the application for a scholarship spot on the page for each training. Please note scholarships only apply to training fees and do not cover transportation, lodging, and meals.
We work with a variety of community partners to bring our trainings to their hometowns. Our programs can be open to the public or private for the members of your organization, and tailored to suit your community’s needs. If you would like to collaborate on holding a training locally, please email us and we’ll start the conversation.
At this time we are not accepting clients for psychedelic integration psychotherapy. If you are seeking a therapist who is trained in this area, please contact the Psychedelic Education & Continuing Care Program or search the therapist listings at psychedelic.support. Additionally you may find this guide to finding a therapist for psychedelic integration helpful.
To learn more about our cancellation policy, attendance policy, CE policy, contact and communication policy, as well as our disclaimer and waiver, please see out policy page.